Hereditary spastic paraplegia (HSP) is characterized by the specific retrograde degeneration of the longest axons in the central nervous system, the corticospinal tracts. The gene most frequently involved in autosomal dominant cases of this disease, SPG4, encodes spastin, an ATPase belonging to the AAA family. AAA proteins are thought to exert their function by the energy-dependent rearrangement of protein complexes. The composite function of these proteins is directed by their binding to regulatory factors and adaptor proteins that target their activity into specific pathways in vivo. We previously found that overexpressed spastin interacts dynamically with microtubules and displays microtubule-severing activity. Here we demonstrate that spastin is enriched in cell regions containing dynamic microtubules.
INTRODUCTION
Hereditary spastic paraplegia (HSP) is a genetically heterogeneous mendelian disorder characterized by weakness, spasticity, and loss of the vibratory sense in the lower limbs (1) (2) (3) . Some forms of HSP are complicated by additional neurological symptoms, but all are characterized by the retrograde degeneration of axons of the corticospinal tracts and the fasciculi gracilis (4, 5) . These tracts contain the longest axons in the central nervous system. HSP represents a model disease to study the processes underlying axonal degeneration, a pivotal cause of neurological impairment in several neurodegenerative diseases (6) .
The most common form of autosomal dominant HSP, accounting for approximately 40% of the cases, is due to mutations in the SPG4 gene (7) . Although it is classified as a pure form of HSP, some studies have identified a slight cognitive impairment as a clinical feature of patients with SPG4 mutations (8) . Age of onset is variable, but usually the first symptoms arise in early adulthood. Nonsense, frame shift, and missense mutations have all been found in SPG4 patients, and are characterized by an indistinguishable clinical phenotype, suggesting that the molecular basis of the disease is haploinsufficiency (9, 10) .
SPG4 encodes spastin, a 616 amino acid protein belonging to the broad AAA (triple A; ATPase Associated with various cellular Activities) family. The signature of the AAA family is a 240 amino acid conserved P-loop NTPase domain, which beside the Walker A and B motifs contains additional sequence conservation, the "second region of homology". AAA proteins are involved in a wide variety of cellular processes, such as cell cycle, vesicular transport, mitochondrial function, peroxisome biogenesis, and proteolysis (11) (12) (13) . Spastin belongs to the poorly characterized subfamily 7, which also contains p60 katanin, a microtubule-severing protein (14) , and SKD1, a regulator of endosome trafficking (15) . Interestingly, the vast majority of missense mutations identified in HSP patients are located in the AAA domain.
AAA proteins are viewed as molecular chaperones that couple ATP hydrolysis to the disassembly and unfolding of protein complexes. The manifold cellular functions of AAA proteins are conferred by the combination of their subcellular localization and the interaction with adaptor proteins that bring them in contact with specific substrates (16) . In some cases, the binding of a single AAA protein to 4 multiple molecules is reflected in its action in seemingly unrelated processes (17, 18) .
All known AAA proteins have a conserved structure, with one of two AAA domains located in the carboxy-terminus of the protein, while the N-terminal part contains recognition sites for substrates and adaptors. Spastin N-terminal region is still poorly characterized, but contains the MIT (found in MIcrotubule-interacting and Trafficking molecules) domain, a recently identified protein motif, which is common to proteins involved in endocytosis and trafficking, such as SKD1, and SNX5 (19) . Notably, the MIT domain is also present in spartin, the product of the SPG20 gene, mutations in which cause Troyer syndrome, an autosomal recessive form of HSP complicated by mental retardation (20) .
The function of spastin is largely unknown. Previous studies performed in our laboratory suggested a role of spastin in microtubule dynamics (21) . We found that overexpressed spastin interacts transiently with microtubules through its N-terminal region, and that this interaction is regulated through the ATPase activity of the AAA domain. Furthermore, we showed that the microtubule network in cells overexpressing spastin is disrupted. We therefore hypothesized that spastin might be implicated in microtubule severing, as shown for the highly homologous p60 katanin, and that impairment of fine regulation of the microtubule cytoskeleton in long axons may underlie pathogenesis of hereditary spastic paraplegia. However, there is still no evidence supporting a role of spastin in cytoskeletal dynamics in vivo.
One major caveat is spastin subcellular localization. Two recent studies have reported partially discrepant results. Charvin et al. found spastin in the nuclei of neuronal cells, while a more recent study detected it in the cytoplasm and/or in the nucleus depending on the neuronal population (22, 23) . Spastin was observed in the cytoplasm and synaptic terminals of cortical and hippocampal pyramidal cells of the cerebral cortex and hippocampus, of Purkinje cells, and of spinal motoneurons (23) .
This composite picture possibly underlies a multifaceted cellular role of spastin.
As a strategy to identify the molecular pathways in which spastin is involved, we combined studies of the subcellular localization of endogenous spastin and searches of spastin adaptor proteins by yeast two-hybrid screenings. Here we present findings indicating that spastin is enriched in cell regions containing dynamic microtubules, such as the centrosomes and the midbody in dividing cells, and the distal axons in motoneurons. As further evidence for a role of spastin in the cytoskeleton, we demonstrate that spastin interacts with the centrosomal protein by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from 5 NA14. The region of spastin interaction with NA14 overlaps with the minimal domain required for microtubule binding in vitro, suggesting that NA14 may be an important adaptor to direct spastin to exert its activity on microtubules at the centrosome. These data strongly argue that one of the pathways in which spastin is implicated may be cytoskeletal dynamics and rearrangement in both proliferating and postmitotic cells.
RESULTS

Spastin localizes to the spindle poles and the midbody during cell division
To get more insights on spastin subcellular localization, we developed rabbit polyclonal antibodies against different regions of spastin and purified them by affinity chromatography. Two affinity-purified antibodies R74 and S51 (directed against spastin fusion proteins comprising amino acid 1-122 and 87-354, respectively) specifically identify transfected spastin as a 68 kDa protein (Fig. 1A, B ). Both antibodies immunoprecipitate an endogenous protein of the same size of transfected spastin from HeLa cell lysates (Fig. 1A, B , black arrowhead). Furthermore, this protein is detected using the S51 antibody for immunoprecipitation and the R74 for western blot (Fig. 1C) , and vice versa (not shown). This protein is not immunoprecipitated by the pre-immune serum and disappears after competitive preincubation with the antigens (not shown). We therefore conclude that the 68 kDa immunoprecipitated protein corresponds to endogenous spastin. We do not detect spastin in total cell lysates by western blot unless we load an extremely high amount of proteins, indicating that spastin is a low abundant protein. Affinity-purified S51 also identifies an additional protein of about 62 kDa in total cell lysates (Fig. 1A, grey arrowhead). We do not know whether this 62 kDa protein represents a cross-reacting 6 We then analyzed spastin subcellular localization in cells undergoing division.
During metaphase, spastin signal concentrates in the centrosomes and on spindle microtubules (Fig. 2D ). This signal is still present on the spindle poles during anaphase and is successfully competed by pre-incubation with the antigen (Fig. 2E,   F ). Spastin is also enriched at the midbody during cytokinesis (Fig. 2G) . To confirm this data, we repeated these experiments with the S51 affinity-purified antiserum. This antibody stains only very weakly the nucleus of cells and the spindle poles (Fig. 2H, I , and not shown), but decorates the central spindle during anaphase (Fig. 2H, I , arrowhead) and the midbody (Fig. 2H, K-M arrows) . These signals are competed by preincubation of the antibody with the antigen (Fig. 2O) shown by co-localization with α-tubulin (Fig. 2J) . At the late stage of cytokinesis, when microtubules are pulled aside, spastin is located at the center of the intercellular bridge ( Fig. 2K-M ).
These data indicate that spastin undergoes dynamic changes in its subcellular localization during the cell cycle. Spastin is mainly nuclear in interphase cells, and becomes associated with the centrosomes, the spindle microtubules, the midzone, and finally the midbody during cell division. All these regions are characterized by striking changes in the dynamic properties of microtubules.
Spastin localizes to distal regions of axons.
We then sought to determine spastin subcellular localization in post-mitotic neurons, and we employed the NSC34 cell line. NSC34 is a hybrid cell line obtained by fusing the aminopterin-sensitive neuroblastoma N18TG2 with motor neuronenriched embryonic day 12-14 spinal cord cells. When NSC34 cells are plated on a matrigel substrate and allowed to differentiate, they acquire a multipolar neuron-like phenotype and possess most of the motoneuronal properties (24) . Consistent with the 7 findings in HeLa, the R74 antibody stains the midbody in dividing NSC34 cells (Fig.   2P , Q).
In differentiated post-mitotic NSC34, the R74 antibody labels discrete nuclear domains in agreement with previous findings (22) , but most interestingly detects a specific signal in the neurites (Fig. 3A) . This signal is not uniformly distributed, but is characteristically enriched in the distal axon and in the branching regions (Fig. 3A,   D ). Spastin is excluded from the most peripheral region of the growth cone, which has highest F-actin content (compare Fig. 3B, C) . This cytoplasmic staining of neurites is highly reminiscent of that observed for tau and MAP1b, two microtubule-associated proteins that are downregulated in axons of adult motoneurons where they are only detected in their distal region (25, 26) . To test this possibility, we double-stained motoneuronal cultures with the R74 antibody and the RT97 monoclonal antibody that recognizes phosphorylated epitopes of high molecular weight neurofilaments, and of the microtubule-associate proteins tau and MAP1b (27) . Co-localization of the two signals was observed at the confocal microscopy ( Fig. 3E, F) .
Isolation of NA14, a centrosomal protein, as a spastin interactor
The complex subcellular localization of endogenous spastin strongly indicates that the protein may serve very different roles, depending on the cell type, and the cell cycle. A composite function is not unusual for AAA proteins, which are frequently involved in different pathways, depending on their localization and binding to adaptor proteins. The identification of molecular partners therefore represents a crucial step to identify these functional pathways.
To isolate candidate spastin interacting molecules, we performed a yeast twohybrid screening of a human fetal brain cDNA library, using full-length human spastin as bait. Screening of 0.5 x 10 6 independent clones led to the isolation of 30 identical clones, corresponding to a partial cDNA, encoding the protein NA14. To ensure that this interaction is specific, the prey was reintroduced into yeast and its ability to grow in the absence of leucine and to induce β-gal activity with the original spastin bait was confirmed (Fig.4 ).
NA14 is a 119 amino acid protein that was originally identified as one of the auto-antigens recognized by the serum of a patient with Sjogren syndrome (28) , and later found to be a component of mammalian centrosomes (29, 30) . The localization 8 of NA14, combined with our finding that spastin associates with centrosomes during cell division, prompted us to investigate this interaction in more detail.
The NA14 clone retrieved by the two-hybrid screening lacks the first 33 amino acids, but comprises an almost complete coiled-coil region and the entire carboxylterminal basic domain of the protein (28) . To identify the region of spastin that is involved in the interaction with NA14, we determined whether spastin deletion constructs would still bind NA14 in the two-hybrid system. This analysis showed that the region of spastin responsible for the interaction with NA14 is located between amino acid 50 and 87 in the N-terminal region (Fig. 4 ). During these studies we also found evidence that NA14 self-associates, as previously reported (28, 29) (Fig. 4 ).
Spastin and NA14 interact in vivo
To determine whether the interaction between spastin and NA14 also occurs in vivo, we performed co-immunoprecipitation experiments in mammalian cells. NA14
is expressed at low levels in several mammalian cell lines including HeLa, hampering to immunoprecipitate the endogenous protein from these cells (28) . We therefore cloned the full length NA14 cDNA in frame with the HA epitope in the pCDNA3 vector, and tested whether endogenous spastin and overexpressed HA-NA14 could be co-immunoprecipitated. This experiment showed that NA14 was detected in the HeLa cell lysate immunoprecipitated by the S51 antibody, but not by the preimmune serum (Fig. 5A ). The S51 antibody detected a weak band corresponding to endogenous spastin, after immunoprecipitation with the anti-HA antibody (not shown). These data suggest that NA14 and spastin can interact in vivo.
Spastin is enriched in purified centrosomal fractions
To gain further evidence for the association of spastin to the centrosome, we asked whether spastin is enriched in centrosomal fractions. We purified centrosomes from HeLa cells by a discontinuous sucrose gradient ultracentrifugation, after removal of swollen nuclei, chromatin aggregates and unlysed cells. This method allows the concentration of centrosomes from an extremely high number of cells (31) . We used the S51 antibody to detect spastin in the different cytoplasmic fractions, and anti γ-or β-tubulin antibodies to distinguish the centrosome-containing fractions. Spastin was detected in the fractions containing γ-tubulin, and not in those containing β-tubulin as 9 expected for a centrosomal protein (Fig. 5B) . The same result was obtained using the R74 antibody (not shown).
The NA14-binding region is involved in microtubule-interaction
We have provided evidence that a fraction of spastin is enriched in the centrosome and in microtubule structures during different phases of the cell cycle in proliferating cells. Moreover, spastin levels are increased in the distal axon, a region where microtubules are highly dynamic. We previously showed that spastin contains a region of interaction with microtubules within its N-terminus (amino acids 1 to 263) (21) . Overexpressed spastin co-sediments with microtubules (21) . The spastinmicrotubule interaction is regulated by the activity of the AAA domain, and can be best revealed by expressing spastin mutants unable to bind and hydrolyze ATP. In fact, when these mutants are expressed in Cos7 cells, they bind stably to a subset of microtubules (21). Since we mapped the region implicated in binding to NA14 within the N-terminal region of spastin, we asked whether binding to NA14 contributes to the microtubule localization of spastin.
To this end, we refined the mapping of the spastin microtubule-interacting region by transfecting a series of spastin deletion constructs, devoid of different parts of the N-terminal region, and testing their ability to co-sediment with taxol-stabilized microtubules. Deletion of the first 50 amino acids of spastin still allows cosedimentation with polymerized microtubules, while removal of the first 87 amino acids prevents it, indicating that the region of spastin comprised between amino acid 50 and 87 is crucial for interaction with microtubules ( Fig. 6A ). To corroborate our findings, we analyzed by immunofluorescence a similar series of N-terminal deleted spastin constructs bearing the K388R mutation and therefore unable to bind ATP ( Fig.   6B-F) . Again, we observed that deletion of the region comprised between amino acid 50 and 87 was sufficient to drastically modify the subcellular localization of the transfected protein, which appeared more diffuse and lost almost completely the ability to co-localize with tubulin (Fig. 6D ). These data suggest that an important region of interaction with microtubules is located between amino acids 50 and 87 and overlaps with that required for binding to NA14. It is interesting to point out that deletion of the MIT domain does not affect spastin interaction with the microtubule network ( Fig. 6 A, F) . We demonstrate that spastin is highly enriched in cellular centrosomal fractions. Moreover, anti-spastin antibodies decorate the spindle poles during cell division, indicating that spastin may concentrate at the centrosome in a cell cycle dependent manner, as demonstrated for many cellular effectors. The centrosome is a tiny, non-membranous organelle usually in close proximity to the nucleus, composed of centrioles and pericentriolar material. This is a dynamic matrix of fibers and protein aggregates, and provides a scaffold for anchoring proteins that are involved in microtubule nucleation and other activities (32) . Spastin may be implicated in severing the microtubule network during mitosis, similarly to p60 katanin (33).
p60 katanin forms an heterodimer with p80 katanin, a WD-40 containing protein, which targets the p60 subunit to the spindle poles and positively regulates its microtubule severing activity (33, 34) . In a search for spastin interacting molecules, we have identified the centrosomal protein NA14 and showed its ability to coimmunoprecipitate with endogenous spastin in vivo. NA14 was originally isolated as one of the two major autoantigens recognized by the serum of a patient with Sjogren syndrome, an autoimmune disease characterized by dry eyes and mouth (28) . The first hint of a possible localization of NA14 to the centrosome came from a study on its
Chlamydomonas reinhardtii orthologue, DIP13 (29) . Chlamydomonas is a unicellular biflagellate green alga that possesses a well-defined microtubule cytoskeleton. DIP13 was found to localize to cytoplasmic microtubules, as well as to basal bodies and flagellar axonemes, which are very similar in structure and function to mammalian centrioles and cilia, respectively. Interestingly, the anti-DIP13 antibody also recognized human NA14 by immunofluorescence and stained basal bodies and flagella of human sperm cells, as well as the centrosome of HeLa cells (29) . With a completely independent approach, NA14 was later confirmed to be a component of human centrosomes in a mass-spectrometry-based proteomic analysis (30) .
The role of NA14/DIP13 at the centrosome is completely unknown. Antisense experiments, in which the levels of DIP13 in Chlamydomonas were reduced, resulted in the appearance of multinucleate and multiflagellate cells, suggesting that DIP13 may be implicated in cell division (29) . The authors conceive that DIP13/NA14 may represent a conserved protein family involved either in a general stabilization of microtubules or in linking microtubular structures to motile systems. The presence in NA14 of a coil-coiled domain makes it a perfect candidate to be a structural centrosomal component. We propose that NA14 is a molecular adaptor involved in targeting spastin to the centrosome, thus triggering the spastin microtubule-severing activity in a specific cellular location and with an exact timing. In support to the hypothesis that NA14 represents a molecular anchor for spastin, we found that deleting the region of spastin involved in the interaction with NA14 abrogates the ability of an ATP-ase defective mutant to associate to microtubule bundles in vitro, and abolishes co-sedimentation of wild-type spastin with microtubules.
The centrosome is not the only site where spastin contacts the microtubule cytoskeleton. In fact we found that spastin is also highly enriched in the midzone or central spindle and at the midbody during cytokinesis. Cytokinesis is a highly regulated process by which two daughter cells physically separates after cell division (35, 36) . A variety of molecules essential for cytokinesis have been localized at the central spindle and at the midbody. Spastin is enriched in these two structures, initially co-localizing with the most central subset of microtubules, and later being restricted to the innermost dense region of the midbody where abscission occurs.
12 microtubule severing activity. Binding to regulatory proteins other than NA14 may be required for targeting spastin to the central spindle and midbody in vivo.
Alternatively, the N-terminus of spastin may be able per se to interact with the cytoskeleton. In fact, a rearrangement of the microtubule cytoskeleton is observed in cells transfected with all types of spastin K388R mutants (Fig. 6) , while all N-terminally deleted wild-type constructs induce microtubule-severing (data not shown).
Association of transfected spastin with the endogenous protein could also underlie these results.
Our data suggest that spastin plays a role in cell division and cytokinesis, and identify NA14 as one of the partners involved. These processes are not affected in HSP patients, who carry SPG4 mutations in the heterozygous state. However, this result is not completely at odds with the neurological phenotype of HSP patients.
Indeed, it has been proposed that proliferating cells and terminally post-mitotic neurons use the same mechanisms and same group of molecular actors to organize their microtubules (38) , and there are multiple examples of proteins with dual function (38) (39) (40) . Among these, p60 katanin is implicated in releasing microtubules from the centrosome during mitosis, as well as in the mechanisms that regulate microtubule length in axons of postmitotic neurons (33, 41) .
We find that spastin is present in the cytoplasm of axons of immortalized motoneurons in vitro, as also observed in human brain specimens (23) . Notably, spastin signal is not uniform, but undergoes a progressive proximal to distal increase, being enriched in the growth cone with the exclusion of its most peripheral region, and in branching points. The distal growth cone and the branching regions are sites of high dynamic events involving microtubules and F-actin (42, 43) . In fact, growth, extension, and precise steering of axons towards synaptic targets depend on a tight control of the dynamics of the cytoskeletal components. To accomplish these tasks, neurons possess a variety of isoforms and of post-translational modifications of cytoskeletal proteins and make use of a vast set of microtubule-associated proteins (44) . Stathmin, a microtubule destabilizing protein, is enriched in the central domain of the growth cones (45) . Mice knockout for stathmin display a late-onset axonal degeneration phenotype remarkably similar to HSP, suggesting that these mechanisms are also important for axon integrity in adult life (46) . We speculate that spastin influences microtubule dynamics in growth cones, thus regulating the stability of axons and axonal transport. These processes are expected to be complex and haploinsufficiency. However, we cannot rule out the hypothesis that the pathogenic mechanism of missense mutations may be dominant-negative, and depend in part on the interference of mutant spastin with the molecular motors that transport cargos on microtubules, as suggested by a study in which mutant spastin was overexpressed in neurons (47).
In conclusion, our findings suggest that spastin is a multi-faceted protein, with a complex function dependent on the cell type, the cell cycle, and the molecular interactor. A survey of spastin involvement in dynamic remodeling of the microtubule cytoskeleton in developing and adult axons promises to be an appealing avenue to follow in order to understand the pathogenesis of HSP. However, this may be only one of the pathways in which spastin is implicated; we and others (22, 23) also found spastin in the nucleus of neurons and the exploration of the nuclear function of spastin could reveal other interesting roles of this versatile AAA molecule.
MATERIALS AND METHODS
Generation of spastin specific antibodies
Two different constructs were used for the production of specific rabbit was expressed in bacteria, purified under native condition as described elsewhere (48) and injected in rabbits at Biogenes (Germany). The anti-spastin rabbit antiserum, S51, was obtained. Both R74 and S51 antisera were affinity purified against their antigens with the NHS Hi-Trap TM affinity columns (Amersham Pharmacia), according to the instructions provided by the manufacturer.
Constructs for expression in mammalian cells
N-terminal deleted spastin cDNAs (∆50-spastin, ∆87-spastin, and ∆190-spastin)
were amplified by PCR using appropriate primers and subcloned into the pMT21-myc vector (EcoRI/SalI). An ATG was recreated at the beginning of each construct. The ∆MIT spastin construct is deleted of the region comprised between nucleotides 340 to 600. This construct was prepared by substituting the fragment EcoRI-XbaI (nucleotides 1 to 600 of spastin open reading frame) of the pMT21-spastin-myc clone (21) with a shorter region corresponding to nucleotides 1 to 340, previously amplified by PCR.
To introduce the point mutations K388R, in vitro mutagenesis was performed using the Quickchange site directed mutagenesis kit (Stratagene, La Jolla, CA), as previously described (21) .
Full length NA14 cDNA was amplified by RT-PCR using HeLa cDNA as template and specific primers designed on available sequence (28) . The resulting fragment was subcloned into the EcoRI and XhoI sites of the pcDNA 3 -HA vector in frame with the HA tag at its N-terminus. In each case the integrity of the clones was determined by direct sequencing.
Cell culture, cell transfection and immunofluorescence
Monkey kidney Cos-7 and HeLa cells were maintained in exponential growth in Alternatively, cells were analysed with a confocal microscope (Leica).
For immunofluorescence the affinity purified spastin specific antibodies were used 1:5. Monoclonal anti α-tubulin (1:250) was from Molecular probes. Monoclonal RT97 was from Development Studies Hybridoma Bank (University of Iowa, IA) (49) (1:50). All the secondary antibodies for immunofluorescence were from Dako (1:200).
Yeast two-hybrid screening
The two-hybrid screening was performed as previously described (50, Samples were subjected to brief sonication (3 x 15 sec) and then centrifuged at 10000 g for 5 min at 4°C to remove cellular debris. Total extracts were pre-cleared with protein A sepharose beads (SIGMA) for 1 hr at 4°C. The precleared lysates were supplemented with the appropriate primary antibody, incubated at 4°C for 3 hrs and the immunocomplexes were then collected on protein A sepharose beads (SIGMA).
Immunoprecipitates were washed with PBS/0.1% Triton-X-100 at least four times.
Immunocomplexes and protein samples were resuspended in SDS sample buffer (20mM Tris/HCl pH 6.8, 2% SDS, 5% β-mercaptoethanol, 2.5% glycerol and 2.5% 
Microtubule co-sedimentation
The microtubule cosedimentation experiments were carried out as previously described (21) . Figure 1 . Characterization of anti-spastin polyclonal antibodies.
LEGENDS TO FIGURES
Proteins from HeLa cells lysates were immunoprecipitated by using the affinitypurified S51 (A) or R74 (B) antibodies. A band corresponding to the size of transfected spastin is detected in both cases (black arrowhead in A and B).
Endogenous spastin is not detectable by western blot on total cell lysate in these conditions, due to low abundance. The S51 antibody also recognizes a band of about 
